Rod Knight1, Mohammad Karamouzian2, Anna Carson3, Joshua Edward4, Patrizia Carrieri5, Jean Shoveller6, Nadia Fairbairn7, Evan Wood7, Danya Fast7. 1. British Columbia Centre on Substance Use, Vancouver, Canada; Department of Medicine, University of British Columbia, Canada. Electronic address: bccsu-rk@bccsu.ubc.ca. 2. British Columbia Centre on Substance Use, Vancouver, Canada; School of Population and Public Health, University of British Columbia, Vancouver, Canada. 3. British Columbia Centre on Substance Use, Vancouver, Canada. 4. British Columbia Centre for Disease Control, Vancouver, Canada. 5. Institute de la Santé et de la Recherché Médical (INSERM), Marseille, France. 6. School of Population and Public Health, University of British Columbia, Vancouver, Canada. 7. British Columbia Centre on Substance Use, Vancouver, Canada; Department of Medicine, University of British Columbia, Canada.
Abstract
BACKGROUND: Methamphetamine use is common among some populations of gay, bisexual and other men who have sex with men (gbMSM). This study reviewed the status of research on the efficacy of interventions that address harms among gbMSM who use methamphetamine. METHODS: We searched MEDLINE, PsycINFO, CINAHL, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Google Scholar to identify publications from inception to October 23, 2017, that assessed an intervention addressing methamphetamine use among gbMSM. RESULTS: Of 1896 potential studies and 935 unique articles screened for inclusion, 28 eligible studies assessed 26 different interventions in the following categories: pharmacological (n = 5); psychosocial (n = 20); harm reduction (n = 1). Given that outcome variables were measured in highly variable ways, we were unable to conduct a meta-analysis of intervention effects. However, 22 studies reported a statistically significant effect on one or more methamphetamine-related outcomes. Among 21 studies that included measures of sexual health-related outcomes, 18 reported a significant effect on one or more sexual health-related outcomes, and 15 of those reported a concurrent effect on both drug- and sexual health-related outcomes. CONCLUSIONS: This is the first review to provide compelling evidence that integrating interventions to address both drug- and sexual-related harms for gbMSM who use methamphetamine can be efficacious. Future research should focus on identifying differential effects of various intervention approaches by social positioning, as well as prioritize future evaluations of integrated harm reduction interventions (e.g., the distribution of harm reduction kits within sexual health care settings).
BACKGROUND:Methamphetamine use is common among some populations of gay, bisexual and other men who have sex with men (gbMSM). This study reviewed the status of research on the efficacy of interventions that address harms among gbMSM who use methamphetamine. METHODS: We searched MEDLINE, PsycINFO, CINAHL, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Google Scholar to identify publications from inception to October 23, 2017, that assessed an intervention addressing methamphetamine use among gbMSM. RESULTS: Of 1896 potential studies and 935 unique articles screened for inclusion, 28 eligible studies assessed 26 different interventions in the following categories: pharmacological (n = 5); psychosocial (n = 20); harm reduction (n = 1). Given that outcome variables were measured in highly variable ways, we were unable to conduct a meta-analysis of intervention effects. However, 22 studies reported a statistically significant effect on one or more methamphetamine-related outcomes. Among 21 studies that included measures of sexual health-related outcomes, 18 reported a significant effect on one or more sexual health-related outcomes, and 15 of those reported a concurrent effect on both drug- and sexual health-related outcomes. CONCLUSIONS: This is the first review to provide compelling evidence that integrating interventions to address both drug- and sexual-related harms for gbMSM who use methamphetamine can be efficacious. Future research should focus on identifying differential effects of various intervention approaches by social positioning, as well as prioritize future evaluations of integrated harm reduction interventions (e.g., the distribution of harm reduction kits within sexual health care settings).
Authors: Annick Bórquez; Katherine Rich; Michael Farrell; Louisa Degenhardt; Rebecca McKetin; Lucy T Tran; Javier Cepeda; Alfonso Silva-Santisteban; Kelika Konda; Carlos F Cáceres; Sherrie Kelly; Frederick L Altice; Natasha K Martin Journal: J Int AIDS Soc Date: 2020-06 Impact factor: 5.396
Authors: Mai Thi Ngoc Tran; Quang Hung Luong; Giang Le Minh; Michael P Dunne; Philip Baker Journal: Front Psychiatry Date: 2021-06-17 Impact factor: 4.157
Authors: C Hamel; K Corace; M Hersi; D Rice; M Willows; P Macpherson; B Sproule; J Flores-Aranda; G Garber; L Esmaeilisaraji; B Skidmore; A Porath; R Ortiz Nunez; B Hutton Journal: Syst Rev Date: 2020-10-24
Authors: Jeremy D Kidd; Margaret M Paschen-Wolff; Amy A Mericle; Billy A Caceres; Laurie A Drabble; Tonda L Hughes Journal: J Subst Abuse Treat Date: 2021-06-16